Frontlight ResearchEarly access
Retinitis pigmentosa trials in United States
27 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Enrolling by invitationA Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
- Where
- Boston, Cincinnati, Cleveland, Dallas, Jacksonville, Miami, Portland
- Age
- 12 years and over
- People
- 24
- Run by
- Beacon Therapeutics
See details and how to joinNCT06275620 - No phaseTaking peopleExperimental and Clinical Studies of Retinal Stimulation
- Where
- Ann Arbor
- Age
- 25 years to 89 years
- People
- 20
- Run by
- University of Michigan
See details and how to joinNCT03635645